Idex Corporation · NYSE:IEX

Idex — Q2 2011 Earnings Presentation

14 slides from Idex's earnings presentation, Jul 25, 2011

  1. Slide 1: Second Quarter 2011 Earnings Release

    Second Quarter 2011 Earnings Release July 21, 2011

  2. Slide 2: Agenda

    Agenda 2 IDEX Mid-Year Assessment Q2 / YTD 2011 Performance CVI Melles Griot Update 2011 Guidance

  3. Slide 3: Replay Information

    Replay Information Dial toll-free: 800.642.1687 International: 706.645.9291 Conference ID: #66065698 Log on to: www.idexcorp.com 3

  4. Slide 4: Cautionary Statement Under the Private Securities Litigation Reform Act

    Cautionary Statement Under the Private Securities Litigation Reform Act This presentation and discussion includes forward-looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those dif

  5. Slide 5: IDEX Mid-Year Assessment

    Operational Excellence Growth Conversion Innovation New Products New Markets Acquisitions Commercial Excellence IDEX Mid-Year Assessment Strong first half results Great global growth Positive price has offset material inflation Organic flow thru of 40% $455M of capital deployed Optics and Photonics

  6. Slide 6: IDEX Q2 2011 Financial Performance

    Total Revenue Operating Margin* Free Cash Flow EPS* IDEX Q2 2011 Financial Performance Continued growth and margin expansion 6 * EPS / Op Margin data adjusted for $1M restructuring expense (2010) and $3M CVI inventory step-up charge (2011). Organic: 8% 24% Growth 130 bps expansion

  7. Slide 7: Fluid & Metering

    Fluid & Metering Double digit orders and sales growth...margin expanded 180 bps 7 Q2 Sales Mix: Organic +16% Acquisition +2% Fx +4% Total +22% Q2 Summary: Executing organic growth initiatives Energy, Chemical, Agriculture all very strong globally Water strong internationally, challenged in the US Ma

  8. Slide 8: Health & Science

    Health & Science Strong sales growth...margin expanded 130 bps 8 Q2 Sales Mix: Organic +10% Acquisition +23% Fx +3% Total +36% Q2 Summary: New product and platform development in life science end markets Industrial and environmental quality control also strong Completed CVI Melles Griot acquisition

  9. Slide 9: Dispensing

    Dispensing Op Margins over 20%...in a difficult environment 9 Q2 Sales Mix: Organic -21% Acquisition - Fx +9% Total -12% Q2 Summary: Wins in Eastern Europe and Asia Latin America markets performing well Retrofit and spare parts driving N.A. revenue Results include $2.8 million gain from building sal

  10. Slide 10: Fire & Safety

    Fire & Safety Great performance in challenging end markets...margins expanded 200 bps 10 Q2 Sales Mix: Organic +3% Acquisition - Fx +5% Total +8% Q2 Summary: BAND IT growing nicely; new applications...expanding the served market Rescue winning internationally North American Fire markets to remain sl

  11. Slide 11: CVI Melles Griot Acquisition Update

    CVI Melles Griot Acquisition Update Integration well underway Building an Optics & Photonics Platform CVI Melles Griot will contribute 7 cents of EPS in 2H'11 (inclusive of purchase accounting amortization, but excluding the non-cash acquisition fair value inventory step-up charge) Purchase accounti

  12. Slide 12: Outlook: 1st Half to 2nd Half Bridge

    Outlook: 1st Half to 2nd Half Bridge 12

  13. Slide 13: Outlook: 2011 Guidance Summary

    Outlook: 2011 Guidance Summary Q3 2011 Adjusted EPS estimate range: $0.60 - $0.62 Organic revenue growth of ~ 8% Positive Fx impact of ~3% to sales (at June 30 rates) Positive impact of 16% from acquisitions FY 2011 Adjusted EPS estimate range: $2.40 - $2.46 Organic revenue growth in the high single

  14. Slide 14: {DEX Proprietary &

    A {DEX Proprietary & Confidential

Idex — Q2 2011 Earnings Presentation on 6ix